Tianjin Chase Sun Pharmaceutical Co Ltd
SZSE:300026
Tianjin Chase Sun Pharmaceutical Co Ltd
Cash from Financing Activities
Tianjin Chase Sun Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tianjin Chase Sun Pharmaceutical Co Ltd
SZSE:300026
|
Cash from Financing Activities
-¥768.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-28%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Financing Activities
-¥818.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Financing Activities
-¥789.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Financing Activities
-¥1.8B
|
CAGR 3-Years
-124%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-36%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Financing Activities
-¥2.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-25%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Cash from Financing Activities
¥365.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Tianjin Chase Sun Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-768.5m
CNY
Based on the financial report for Dec 31, 2023, Tianjin Chase Sun Pharmaceutical Co Ltd's Cash from Financing Activities amounts to -768.5m CNY.
What is Tianjin Chase Sun Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-28%
Over the last year, the Cash from Financing Activities growth was -410%.